B Cell News and Research

RSS

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Inovio Pharmaceuticals, Inc. announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest.

24 Sep 2014

UC Riverside collaborating on NSF-funded project to study ancient lineages of fungi

The University of California, Riverside is one of 11 collaborating institutions that have been funded a total of $2.5 million by the National Science Foundation for a project focused on studying zygomycetes - ancient lineages of fungi that include plant symbionts, animal and human pathogens and decomposers of a wide variety of organic compounds.

24 Sep 2014

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

A new study published in the prestigious publication The EMBO Journal shows that the mitochondrial protein Mfn2 may be a future therapeutic target for neuronal death reduction in the late phases of an ischemic stroke.

24 Sep 2014

Scientists identify way to find proverbial needle in cancer antigen haystack

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

24 Sep 2014

Rice University research yields new two-step strategy for weakening cancer

Research by Rice University scientists who are fighting a cyberwar against cancer finds that the immune system may be a clinician's most powerful ally.

24 Sep 2014

UW-Madison and Morgridge researchers are creating tissue chip technology to screen neural toxins

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.

24 Sep 2014

Alectinib promise for crizotinib-resistant NSCLC

Alectinib has shown promising antitumour activity in patients with ALK-rearranged non-small-cell lung cancer that is resistant to crizotinib, researchers report.

23 Sep 2014

Scientists identify gene mutation that causes aplastic anemia

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells.

23 Sep 2014

Circulating tumour cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

EKF, announces that it has entered into a two year research collaboration with Massachusetts General Hospital.

From EKF Diagnostics 23 Sep 2014

New Jersey physician offers FDA-approved non-invasive fat reduction treatment

Arthur W. Perry, MD, FACS, a New Jersey based board-certified plastic surgeon, is the first physician in the Central New Jersey region to offer UltraShape™, a revolutionary treatment recently FDA cleared for Fat Cell Destruction.

23 Sep 2014

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Cedars-Sinai physicians and scientists are testing a novel, human cell based, bioartificial liver support system for patients with acute liver failure, often a fatal diagnosis.

23 Sep 2014

Influenza can cause ear and throat infections

Influenza infection can enhance the ability of the bacterium Streptococcus pneumoniae to cause ear and throat infections, according to research published ahead of print in the journal Infection and Immunity.

23 Sep 2014

Promising new approach for combating colorectal cancer

Scientists at the University of York are working on a promising new approach for tackling colorectal cancer, the second most common cause of cancer-related death.

23 Sep 2014

Researchers demonstrate how Parkinson's disease spreads in the human brain

An international, interdisciplinary group of researchers led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has demonstrated, through the use of a new antibody, how Parkinson's disease spreads from cell to cell in the human brain.

23 Sep 2014

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Analysis of circulating tumor cells (CTCs) in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases.

23 Sep 2014

Daktari receives NIH SBIR grant to develop point-of-care sickle cell diagnostic test

Daktari Diagnostics, in collaboration with Harvard University, the Medical University of South Carolina, and the University of Zambia in Lusaka, is thrilled to announce that it has been awarded a Small Business Innovation Research grant by the National Institute of Health for a point-of-care sickle cell diagnostic test.

23 Sep 2014

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Avalon Ventures today announced the launch of two new companies formed through its collaboration with GlaxoSmithKline to fund and launch up to 10 early-stage life science companies.

23 Sep 2014

Immature blood vessels linked to poor sunitinib response

Patients with clear-cell renal cell carcinoma with relatively mature blood vessels respond better to sunitinib and have fewer metastatic sites than those with immature vessels, a study has found.

22 Sep 2014

Amgen seeks FDA approval for leukemia drug blinatumomab

Amgen today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab.

22 Sep 2014

TxCell to provide update on immunotherapy products at Société Générale Healthcare & Biotechnology Conference

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it will participate at the Société Générale Healthcare & Biotechnology Conference.

22 Sep 2014

B Cell News and Research

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

UC Riverside collaborating on NSF-funded project to study ancient lineages of fungi

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

Scientists identify way to find proverbial needle in cancer antigen haystack

Rice University research yields new two-step strategy for weakening cancer

UW-Madison and Morgridge researchers are creating tissue chip technology to screen neural toxins

Alectinib promise for crizotinib-resistant NSCLC

Scientists identify gene mutation that causes aplastic anemia

Circulating tumour cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

New Jersey physician offers FDA-approved non-invasive fat reduction treatment

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Influenza can cause ear and throat infections

Promising new approach for combating colorectal cancer

Researchers demonstrate how Parkinson's disease spreads in the human brain

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Daktari receives NIH SBIR grant to develop point-of-care sickle cell diagnostic test

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Immature blood vessels linked to poor sunitinib response

Amgen seeks FDA approval for leukemia drug blinatumomab

TxCell to provide update on immunotherapy products at Société Générale Healthcare & Biotechnology Conference

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News